Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phytosterols decrease prostaglandin release in cultured P388D1/MAB macrophages.

Atif B Awad1, Jeffrey Toczek, Carol S Fink

  • 1Department of Exercise and Nutrition Sciences, University of Buffalo, 15 Farber Hall, 3435 Main Street, Buffalo, NY 14214, USA. awad@buffalo.edu

Prostaglandins, Leukotrienes, and Essential Fatty Acids
|May 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Phytosterols in Cancer Prevention and Treatment.

Journal of AOAC International·2015
Same author

L-arginine and nitric oxide in CNS function and neurodegenerative diseases.

Critical reviews in food science and nutrition·2013
Same author

Vitamin D and multiple sclerosis.

Critical reviews in food science and nutrition·2012
Same author

Statin therapy depresses fat metabolism in older individuals.

Journal of the American College of Nutrition·2012
Same author

Regulatory approval of plant sterols in Canada: implications for health care and clinical practice.

Canadian journal of dietetic practice and research : a publication of Dietitians of Canada = Revue canadienne de la pratique et de la recherche en dietetique : une publication des Dietetistes du Canada·2012
Same author

Vitamin d and metabolic syndrome risk factors: evidence and mechanisms.

Critical reviews in food science and nutrition·2011
Same journal

Cardiovascular safety profile of prostaglandin E and prostacyclin analogues: Clinical reports and ex vivo studies on human coronary arteries.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Specialized pro-resolving mediator (SPM)-enriched supplementation modulates inflammatory biomarkers in patients with symptomatic knee osteoarthritis: Blood plasma analysis from the GAUDI study.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Serum fatty acid distributions and prevalence of low omega-3 status in early pregnancy: A cross-sectional analysis of 26,389 samples from an omega-3 test-and-treat program.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Association of fish intake with systemic immune-inflammation index: Potential mediating role of n-3 polyunsaturated fatty acids.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

A novel algae oil-based emulsion enhances chemotherapy outcome in human cancer models.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Human milk omega-3 PUFA and infant neurodevelopment: Evidence and insights from indian mothers.

Prostaglandins, leukotrienes, and essential fatty acids·2026
See all related articles

Phytosterols like beta-sitosterol significantly reduce prostaglandin release from macrophages, offering potential protection against atherosclerosis by slowing atheroma development.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cardiovascular Research

Background:

  • Cardiovascular disease (CVD) is a leading cause of death, with atherosclerosis accounting for 50% of US mortality.
  • Plant-based diets and phytosterols, particularly beta-sitosterol, are linked to reduced cardiovascular disease incidence.
  • Macrophages play a key role in atherosclerosis by accumulating in arteries and releasing prostaglandins.

Purpose of the Study:

  • To investigate the impact of phytosterols on prostaglandin E2 (PGE2) and prostacyclin I2 (PGI2) release from macrophage cells.
  • To determine if phytosterols affect macrophage cellular growth and membrane composition.

Main Methods:

  • P388D1/MAB macrophage cells were supplemented with cholesterol, beta-sitosterol, or campesterol (16 microM) using cyclodextrin.

Related Experiment Videos

  • Cellular growth and sterol incorporation into cell membranes were monitored over 7 days.
  • Prostaglandin release (PGE2, PGI2) was measured in lipopolysaccharide (LPS)-stimulated cells.

    • Main Results:

    • Phytosterol supplementation significantly decreased macrophage cellular growth, particularly after 3 days.
    • Macrophages incorporated phytosterols into membranes, comprising 26% of total sterols; cholesterol had no effect.
    • Beta-sitosterol and campesterol significantly inhibited PGE2 and PGI2 release compared to controls.
    • Beta-sitosterol showed a greater inhibitory effect (68% for PGE2, 67% for PGI2) than campesterol (55% for PGE2, 52% for PGI2).
    • Cholesterol supplementation also decreased prostaglandin release, but to a lesser extent (37% for PGE2, 35% for PGI2).
    • Decreased prostaglandin release was not linked to changes in cPLA2 and COX-2 enzyme expression.

    Conclusions:

    • Phytosterol incorporation into macrophages reduces prostaglandin release.
    • This reduction in prostaglandins may offer protection against atherosclerosis by inhibiting atheroma development.
    • Phytosterols, especially beta-sitosterol, demonstrate potential therapeutic benefits for cardiovascular health.